Literature DB >> 20694755

Clomipramine treatment and repeated restraint stress alter parameters of oxidative stress in brain regions of male rats.

Rodrigo de Souza Balk1, Jessika Cristina Bridi, Rafael de Lima Portella, Nelson Rodrigues Carvalho, Fernando Dobrachinski, Michele Hinerasky da Silva, Guilherme Pires Amaral, Glaecir Roseni Mundstock Dias, Nilda de Vargas Barbosa, Felix Alexandre Antunes Soares.   

Abstract

This study aimed to compare the effects of repeated restraint stress alone and the combination with clomipramine treatment on parameters of oxidative stress in cerebral cortex, striatum and hippocampus of male rats. Animals were divided into control and repeated restraint stress, and subdivided into treated or not with clomipramine. After 40 days of stress and 27 days of clomipramine treatment with 30 mg/kg, the repeated restraint stress alone reduced levels of Na(+), K(+)-ATPase in all tissues studied. The combination of repeated restraint stress and clomipramine increased the lipid peroxidation, free radicals and CAT activity as well as decreased levels of NP-SH in the tissues studied. However, Na(+), K(+)-ATPase level decreased in striatum and cerebral cortex and the SOD activity increased in hippocampus and striatum. Results indicated that clomipramine may have deleterious effects on the central nervous system especially when associated with repeated restraint stress and chronically administered in non therapeutic levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694755     DOI: 10.1007/s11064-010-0240-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Does oxidative stress contribute in tricyclic antidepressants-induced cardiotoxicity?

Authors:  Ebtehal El-Demerdash; Ahmed M Mohamadin
Journal:  Toxicol Lett       Date:  2004-09-10       Impact factor: 4.372

2.  Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).

Authors:  Daniele Consoli; Julia Fedotova; Vincenzo Micale; Nikolay S Sapronov; Filippo Drago
Journal:  Eur J Pharmacol       Date:  2005-09-27       Impact factor: 4.432

Review 3.  Worldwide use of clomipramine.

Authors:  M R Trimble
Journal:  J Clin Psychiatry       Date:  1990-08       Impact factor: 4.384

4.  The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats.

Authors:  B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Neuroscience       Date:  2006-09-27       Impact factor: 3.590

5.  Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture.

Authors:  M Lai; J A McCormick; K E Chapman; P A T Kelly; J R Seckl; J L W Yau
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

6.  Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture.

Authors:  L J McIntosh; R M Sapolsky
Journal:  Exp Neurol       Date:  1996-10       Impact factor: 5.330

Review 7.  Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.

Authors:  Rebecca Graumann; Irmgard Paris; Pedro Martinez-Alvarado; Pamela Rumanque; Carolina Perez-Pastene; Sergio P Cardenas; Pablo Marin; Fernando Diaz-Grez; Raul Caviedes; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Pol J Pharmacol       Date:  2002 Nov-Dec

8.  Glutathione as a cerebral substrate in depressive behavior.

Authors:  S N Pal; P C Dandiya
Journal:  Pharmacol Biochem Behav       Date:  1994-08       Impact factor: 3.533

9.  Protective effect of glutathione on kainic acid-induced neuropathological changes in the rat brain.

Authors:  A Saija; P Princi; A Pisani; M Lanza; M Scalese; E Aramnejad; R Ceserani; G Costa
Journal:  Gen Pharmacol       Date:  1994-01

Review 10.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

View more
  5 in total

1.  Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice.

Authors:  Morgana Moretti; Josiane Budni; Danubia Bonfanti Dos Santos; Alessandra Antunes; Juliana Felipe Daufenbach; Luana Meller Manosso; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  J Mol Neurosci       Date:  2012-10-03       Impact factor: 3.444

2.  Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice.

Authors:  Vishnu N Thakare; Valmik D Dhakane; Bhoomika M Patel
Journal:  Metab Brain Dis       Date:  2016-10-26       Impact factor: 3.584

3.  In Vivo Antistress Effects of Synthetic Flavonoids in Mice: Behavioral and Biochemical Approach.

Authors:  Mehreen Ghias; Syed Wadood Ali Shah; Fakhria A Al-Joufi; Mohammad Shoaib; Syed Muhammad Mukarram Shah; Muhammad Naeem Ahmed; Muhammad Zahoor
Journal:  Molecules       Date:  2022-02-18       Impact factor: 4.411

4.  Chronic clomipramine treatment reverses depressogenic-like effects of a chronic treatment with dexamethasone in rats.

Authors:  Abderrahim Laaziz; Hicham El Mostafi; Aboubaker Elhessni; Tarik Touil; Hanane Doumar; Abdelhalem Mesfioui
Journal:  IBRO Neurosci Rep       Date:  2022-08-01

5.  Effect of Beta vulgaris Linn. Leaves Extract on Anxiety- and Depressive-like Behavior and Oxidative Stress in Mice after Acute Restraint Stress.

Authors:  Kunjbihari Sulakhiya; Vikas Kumar Patel; Rahul Saxena; Jagrati Dashore; Amit Kumar Srivastava; Manoj Rathore
Journal:  Pharmacognosy Res       Date:  2016 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.